1. Home
  2. DH vs SEER Comparison

DH vs SEER Comparison

Compare DH & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

HOLD

Current Price

$0.95

Market Cap

112.1M

Sector

Technology

ML Signal

HOLD

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.91

Market Cap

108.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DH
SEER
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.1M
108.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
DH
SEER
Price
$0.95
$1.91
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $3.08
N/A
AVG Volume (30 Days)
★ 1.1M
176.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.28
9.40
EPS
N/A
★ N/A
Revenue
★ $241,521,000.00
$16,578,000.00
Revenue This Year
N/A
$2.14
Revenue Next Year
$0.74
$25.90
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.99
52 Week Low
$0.61
$1.55
52 Week High
$4.06
$2.41

Technical Indicators

Market Signals
Indicator
DH
SEER
Relative Strength Index (RSI) 53.80 45.78
Support Level $0.91 $1.83
Resistance Level $1.01 $1.93
Average True Range (ATR) 0.05 0.05
MACD -0.01 -0.00
Stochastic Oscillator 40.09 65.00

Price Performance

Historical Comparison
DH
SEER

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: